Quantcast

Latest Management of cancer Stories

2014-09-18 12:29:06

Free public open house to feature center tours, food and a chance to meet doctors and staff HAZLETON, Pa., Sept. 18, 2014 /PRNewswire/ -- In partnership with the American Cancer Society, Cancer Treatment Center at Hazleton announces the opening of the ACS Cancer Resource Center for local patients and the community. The Resource Center is now open from 10 a.m. to 4 p.m. on Mondays and Thursdays. http://photos.prnewswire.com/prnvar/20140917/146887 Located inside the Cancer Treatment...

2014-09-18 12:27:44

Several Emerging Therapies Will Expand Treatment Armamentarium for Unresectable Locally Advanced or Metastatic Gastric Cancer, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 18, 2014 /PRNewswire/ -- Decision Resources Group finds that the gastric cancer market will grow exponentially from over $1.1 billion in 2013 to nearly $3.8 billion by 2023. Fuelling this growth will be the launch of five targeted therapies for unresectable locally advanced and metastatic...

2014-09-17 16:27:04

SAN DIEGO and PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), disclosed today that each company will be presenting at the 2014 Exosomes & SingleCell Analysis Summit. http://photos.prnewswire.com/prnvar/20130912/LA78266LOGO On September 18(th),...

2014-09-15 23:07:35

Cianna Medical, Inc: Studies show benefit of targeted radiation for early-stage breast cancer Aliso Viejo, Calif. (PRWEB) September 15, 2014 Cianna Medical, Inc., a women’s health company, today announced five-year results for the first 200 hundred patients treated with the SAVI® breast brachytherapy applicator, including excellent local control, low rates of toxicities and excellent cosmetic results. An additional study of nearly 600 patients with over three years of follow-up...

2014-09-15 16:28:12

Multidisciplinary team composed of six organizations awarded $20,000 for groundbreaking work in mesothelioma and non-small cell lung cancer SYDNEY, Sept. 15, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that, together with the Asbestos Disease Research Institute (ADRI), it has received the 2014 Cancer Institute New...

2014-09-15 08:29:25

Unusually broad range of tumors treated, other benefits seen in first seven months SAN FRANCISCO, Sept. 15, 2014 /PRNewswire/ -- The nation's first proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care in February. Carl Rossi, M.D., medical director of the Scripps Proton Therapy Center in San Diego, offered the assessment in San Francisco, where the American Society...

2014-09-11 08:28:17

Hosting an educational symposium highlighting treatment advances using the Company's high-dose rate electronic brachytherapy system NASHUA, N.H. and SAN FRANCISCO, Sept. 11, 2014 /PRNewswire/ -- (Booth #1938) -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, will debut the Company's latest technological advances and present updates on clinical data and patient...

2014-09-10 12:24:45

Behind The Bench, The National Basketball Wives Association and The Leukemia & Lymphoma Society Team up for Cancer Cures WHITE PLAINS, N.Y., Sept. 10, 2014 /PRNewswire-USNewswire/ -- 11-year-old Kyle Markes passed away of acute lymphoblastic leukemia (ALL) on December 24, 2013, just days before he was set to be his idol Kevin Durant's special guest at an Oklahoma Thunder game on Christmas Day. Every three minutes, someone in the U.S. is diagnosed with a blood cancer. Almost 150,000...

2014-09-09 08:31:36

Additional Data Acceptances Include Multiple Oncotype DX® Studies in Breast and Renal Cancers REDWOOD CITY, Calif., Sept. 9, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in prostate, breast and renal cancers will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, September 26 - 30. Included in the program is the first presentation of strongly positive results from an...

2014-09-05 20:21:03

Horses with melanoma are the subject of this major clinical study TAMPA, Fla., Sept. 5, 2014 /PRNewswire/ -- Morphogenesis Inc., the biotechnology firm developing ImmuneFx(TM), a cancer vaccine that has improved the longevity and quality of life for dogs, cats and horses, announces that a formal equine clinical trial for the direct injection form of the vaccine will begin later this month at a large equine facility in Missouri. Pat Lawman, PhD., co-founder and CEO of Morphogenesis...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related